Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
NCT Number: NCT03342508
The purpose of this study is to evaluate outcomes following cesarean delivery for failure to progress with the use of the Fetal Pillow. Our hypothesis is that time to delivery of the fetus is shorter with implementation of the Fetal Pillow.
Looking for future studies?
Notify Me18 year–50 year
Female
Interventional
Not applicable
Boston, Massachusetts, 02115, United States
Women will be enrolled from the labor floor during their labor course when there is concern for cesarean section for failure to progress in the second stage of labor. These women may be approached if they have a prolonged labor course (before they reach full dilation), when they get to full dilation and start pushing, or following an unsuccessful operative delivery. All women who meet the inclusion criteria will be approached about participation in the study on labor and delivery. The process of informed consent will happen at that time on labor and delivery. All women will be enrolled by study staff or certain physicians at Brigham and Women's Hospital who have agreed to help consent patients for this study.
Once consent is obtained, the subjects will then be randomized 1:1 into two parallel groups, the Fetal Pillow Inflated (FPI) group and the Fetal Pillow Not Inflated (FPNI) group. A random number generator will allocate the groups in blocks of ten.
The Fetal Pillows used in the study have been donated by Safe Obstetrics Systems.
Each patient will have a Fetal Pillow inserted vaginally by the obstetrician after catheterization of the bladder (if it has not been previously performed). Once the Fetal Pillow is in place, the woman's legs will be placed flat on the operating table. The anesthesiologist will then inflate the Fetal Pillow if the patient has been randomized into the Fetal Pillow Inflated (FPI) group. In the Fetal Pillow Not Inflated (FPNI) group, the device will remain, not inflated, in the vagina. The obstetrician will therefore be blinded to the intervention. In the FPNI group the obstetrician will continue to be able to use conventional methods for delivery of a second stage arrest including hand from below and reverse breech extraction. The Fetal Pillow will be drained by the circulating nurse in the operating room following delivery with removal at the end of the procedure by the obstetrician.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
see arm description
Time frame: Assessed at time of delivery, delivery day (day 0)
Time (in seconds) from hysterotomy to delivery
Time frame: Assessed at time of delivery, delivery day (day 0)
Score of difficulty of delivery 1-5 (1: very difficult, 5: very easy)
Time frame: Assessed at time of delivery, delivery day (day 0)
Grading of extension 1-3
Time frame: Assessed both following delivery (day 0) and at end of study period (week 4)
Blood loss, presence of blood transfusion, change in hematocrit from preop to postop day 1, temperature>100.4, ICU transfer, presence of Disseminated intravascular coagulation (DIC), readmission
Time frame: Assessed at end of study period (week 4)
Maternal Length of stay
Time frame: Assessed at time of delivery, delivery day (day 0)
Weight of fetus at time of birth
Time frame: Assessed at time of delivery, delivery day (day 0)
Assessment of the 1 minute APGAR
Time frame: Assessed at time of delivery, delivery day (day 0)
Assessment of the 5 minute APGAR
Time frame: Assessed at end of study period (week 4)
Need for intubation, fetal trauma
Time frame: Assessed at end of study period (week 4)
Length of stay in NICU
Time frame: Assessed at end of study period (week 4)
Willingness to recommend to others based on ease of placement and removal (1-5 point scale)
Brigham and Women's Hospital
Other
Outcomes Following Cesarean Delivery for Failure to Progress With Use of a Fetal Pillow
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06528340
Advanced Maternal Age Pregnancy, Cesarean Section Complications
Scorrano, Lecce, Italy
View Trial DetailsNCT03471858
Cesarean Section; Dehiscence, Female Urogenital Diseases and Pregnancy Complications
Singapore
View Trial DetailsNCT05674838
Cardiovascular Diseases, Female Urogenital Diseases and Pregnancy Complications
Cincinnati, Ohio, United States
View Trial DetailsNCT07056062
Dystocia, Female Urogenital Diseases and Pregnancy Complications
Colton, California, United States
View Trial Details